Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Syngene International Ltd. ( (IN:SYNGENE) ) is now available.
Syngene International Ltd. announced a scheduled meeting with USB Securities, an analyst/institutional investor, to be held on November 28, 2025, in Mumbai. The company assured that no unpublished price-sensitive information will be disclosed during this meeting, reflecting its commitment to transparency and regulatory compliance.
More about Syngene International Ltd.
Syngene International Ltd. operates in the biotechnology industry, providing integrated research, development, and manufacturing services. The company focuses on delivering innovative solutions to pharmaceutical, biotechnology, and other life sciences sectors.
Average Trading Volume: 64,839
Technical Sentiment Signal: Sell
Current Market Cap: 253.7B INR
See more insights into SYNGENE stock on TipRanks’ Stock Analysis page.